Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q Autor Adema, V, Palomo, L, Walter, W, Mallo, M, Hutter, S, La Framboise, T, Arenillas, L, Meggendorfer, M, Radivoyevitch, T, Xicoy, B, Pellagatti, A, Haferlach, C, Boultwood, J, Kern, W, Visconte, V, Sekeres, M, Barnard, J, Haferlach, T, Solé, F, Maciejewski, JP

Recurrent genetic defects on chromosome 5q in myeloid neoplasms Autor Hosono, N, Makishima, H, Mahfouz, R, Przychodzen, B, Yoshida, K, Jerez, A, LaFramboise, T, Polprasert, C, Clemente, M, Shiraishi, Y, Chiba, K, Tanaka, H, Miyano, S, Sanada, M, Cui, E, Verma, A, McDevitt, M, List, A, Saunthararajah, Y, Sekeres, M, Boultwood, J, Ogawa, S, Maciejewski, J

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Autor Jerez, A, Sugimoto, Y, Makishima, H, Verma, A, Jankowska, A, Przychodzen, B, Visconte, V, Tiu, R, O'Keefe, C, Mohamedali, A, Kulasekararaj, A, Pellagatti, A, McGraw, K, Muramatsu, H, Moliterno, A, Sekeres, M, McDevitt, M, Kojima, S, List, A, Boultwood, J, Mufti, G, Maciejewski, J

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS Autor Malcovati, L, Stevenson, K, Papaemmanuil, E, Neuberg, D, Bejar, R, Boultwood, J, Bowen, DT, Campbell, PJ, Ebert, BL, Fenaux, P, Haferlach, T, Heuser, M, Jansen, JH, Komrokji, RS, Maciejewski, JP, Walter, MJ, Fontenay, M, Garcia-Manero, G, Graubert, TA, Karsan, A, Meggendorfer, M, Pellagatti, A, Sallman, DA, Savona, MR, Sekeres, M, Steensma, DP, Tauro, S, Thol, F, Vyas, P, Van de Loosdrecht, AA, Haase, DT, Tuechler, H, Greenberg, PL, Ogawa, S, Hellstrom-Lindberg, ES, Cazzola, M